PPARγ Agonists

PPARγ Agonists — contains compounds of the thiazolidinedione class and thioacetic acid derivatives that bind to the nuclear receptor PPAR gamma to modulate the expression of genes related to lipid and glucose metabolism. This category serves as a key structural reference in nuclear receptor agonist research in the field of endocrinology.

PPARγ Agonists such as Troglitazone, Rosiglitazone, and Pioglitazone are used by researchers in nuclear receptor signaling pathway studies to understand the regulation of adipogenesis, insulin sensitivity, and fat cell differentiation in in vitro models. Structural comparator compounds such as thioacetic acid derivatives are also used to map structure-activity relationships in the development of new PPAR gamma ligands in diabetes and obesity research laboratories.

Product examples in this collection: TCI T3920 97322-87-7 Troglitazone, TCI C1323 50892-23-4 [4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic Acid, TCI T3787 2921-20-2 2-(Tetradecylthio)acetic Acid, TCI P1901 112529-15-4 Pioglitazone Hydrochloride, TCI R0271 155141-29-0 Rosiglitazone Maleate, TCI R0106 122320-73-4 Rosiglitazone.

Pay attention to the salt form (for example maleate or hydrochloride) and the compound purity, as both factors affect solubility when preparing stock solutions for accurate receptor activity assays. All products are genuine Tokyo Chemical Industry (TCI) Japan products, with purity, packaging, and storage conditions listed on each item's page.

Other parallel categories under Obesity and Diabetes Research, often used together in one laboratory workflow:

Back to Obesity and Diabetes Research. For large-volume procurement, special packaging, or specific grades, contact the AMI Scientific team — the official distributor of TCI Japan in Indonesia — to check availability and lead time directly from Japan.

Related TCI catalogs (PDF)

5 products